Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Brave Care

Explore full profile

Operates healthcare clinics intended to offer urgent childcare services

Portland, United StatesFounded 2017Health Tech & Medtech
Valuation $100–500M Latest valuation · 2021
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Brave Care and the history behind them.

About Brave Care

Brave Care operates in the healthcare sector, specializing in pediatric primary and urgent care services. The company serves families with children, offering a range of medical services including same-day appointments, home vaccine visits, and a 24/7 nurse line for remote care guidance. Brave Care's business model focuses on providing high-quality, affordable care in modern, clean, and kid-friendly environments. Revenue is generated through direct patient services and possibly through partnerships with insurance providers. The company aims to ease parental concerns by offering convenient and accessible healthcare solutions for children. Keywords: pediatric care, urgent care, primary care, home vaccines, 24/7 nurse line, same-day appointments, kid-friendly, affordable healthcare, remote guidance, family-focused.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
Portland, United States
Employees
16
Open positions
None listed
Dealroom signal
64.8/100
Industry
Health, Kids
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Health Care, Environment, Children, YC S19
Business model
SaaS
Client focus
b2c

Latest news

Press, funding announcements and product moves mentioning Brave Care.

See all news

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BEquity / VC Oct 2021 $25M $100M Pediatrix Medical
SERIES AEquity / VC Apr 2021 $10M $40M Indicator Ventures · Gaingels · AV8 Ventures · Refactor Capital
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Brave Care website traffic

Latest recorded traffic for Brave Care is 2.1K monthly website visits, up 187.7% over the last three months. Brave Care's team declined 69.8% over the past year.

Latest monthly visits2.1K 3-month web change+187.7% 1-year team growth-69.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

20 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A9 investors entered at this stage

Other known investors9 additional known investors

Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States90%
🇵🇱 Poland10%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Brave Care on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Brave Care’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.